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Nuclear Receptor Coactivator ACTR Is a Novel
Histone Acetyltransferase and Forms a Multimeric
Activation Complex with P/CAF and CBP/p300
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and RAR, hormone-independent repression. Further*Howard Hughes Medical Institute
studies showed that the integrity of a well-conserved²The Salk Institute for Biological Studies
amphipathic a helix (AF2/tc domain) located in the ex-La Jolla, California 92037
treme C termini of receptors is required for both the³Graduate Program in Molecular Pathology
ligand-induced conformational change and the hor-School of Medicine
mone-dependent transactivation activity (Barettino etUniversity of California at San Diego
al., 1994; Durand et al., 1994; Baniahmad et al., 1995;La Jolla, California 92037
Leng et al., 1995; Schulman et al., 1996).§Laboratory of Molecular Growth Regulation
The mechanism of transcriptional regulation by nu-National Institute of Child Health and Human
clear receptors has been a focus of intense study. TheDevelopment
demonstration of direct interaction of receptor with theNational Institutes of Health
basal transcription factors, such as TFIIB and TBP (IngBethesda, Maryland 20892
et al., 1992; Baniahmad et al., 1993; Fondell et al., 1993;‖Section of Microbiology
Blanco et al., 1995; Schulman et al., 1995), suggestedDivision of Biological Sciences
that liganded receptor may directly influence the func-University of California at Davis
tion of basal transcription machinery. However, theseDavis, California 95616
direct interaction models do not explain transcriptional
squelching betweenreceptors (Meyer et al., 1989; Baret-
tino et al., 1994) or the role of receptor-associated cofac-
Summary tors (for review, see Horwitz et al., 1996). In order to
understand the molecular mechanism of transcription
We report here the identification of a novel cofactor, repression mediated by nuclear hormone receptors, we
ACTR, thatdirectly binds nuclear receptors and stimu- and others have isolated a family of proteins including
SMRT/TRAC and N-CoR/RIP13 (Chen and Evans, 1995;lates their transcriptional activities in a hormone-
Horlein et al., 1995; Soel et al., 1995; Sande and Prival-dependent fashion. ACTR also recruits two other nu-
sky, 1996) that interact with receptors in the absenceclear factors, CBP and P/CAF, and thus plays a central
of hormone and act as transcriptional corepressors forrole in creating a multisubunit coactivator complex.
TR and RAR. Recently, the continuing search for cofac-In addition, and unexpectedly, we show that purified
tors that mediate ligand-dependent transactivationACTR is a potent histone acetyltransferase and ap-
function of the nuclear hormone receptors led to thepears to define a distinct evolutionary branch to this
finding that CBP and its homolog p300 can interact withrecently described family. Thus, hormonal activation
several nuclear receptors and potentiate their transacti-by nuclear receptors involves the mutual recruitment
vation activity (Chakravarti et al., 1996; Hanstein et al.,of at least three classes of histone acetyltransferases
1996; Kamei et al., 1996; Yao et al., 1996). In addition,that may act cooperatively as an enzymatic unit to
it was also shown that CBP and p300 can form a com-reverse the effects of histone deacetylase shown to
plex with SRC-1, a recently cloned transcriptional co-be part of the nuclear receptor corepressor complex.
activator for steroid receptors (Onate et al., 1995;
Hanstein et al., 1996; Kamei et al., 1996; Yao et al., 1996).
Introduction These recent findings suggest that bridging protein fac-
tors exist and function to transmit the signal of ligand-
Nuclear hormone receptors for steroids (such as GR induced conformational change to the basal transcrip-
and ER), retinoids (RARs and RXRs), thyroid hormone tion machinery.
(TRs), vitamin D3 (VDR), and prostanoids (PPARs) com- CBP and p300 are large nuclear proteins and have
prise a large family of sequence-specific transcription been demonstrated to interact functionally with a num-
factors. They play diverse roles in the control of cell ber of sequence-specific transcriptional activators (for
growth and differentiation, development, and homeo- review, see Janknecht and Hunter, 1996), including
stasis by stimulating or repressing target gene expres- CREB (Chrivia et al., 1993; Arany et al., 1994; Kwok et al.,
sion (Mangelsdorf et al., 1995). Nuclear receptors bind 1994), bHLH factors (Eckner et al., 1996), Stat proteins
to their response elements on the target gene promoter (Bhattacharya et al., 1996; Zhang et al., 1996), AP1 (Arias
as either homodimers, heterodimers, or monomers. In et al., 1994; Bannister and Kouzarides, 1995), NF-kB
the case of heterodimers, RXR has been shown to be (Perkins et al., 1997) and nuclear receptors (referenced
as above) as well as general transcription factors TFIIBthe common partner for receptors such as RARs, TRs,
and TBP, the oncoprotein E1A, and a human histoneand VDRs (for review, see Mangelsdorf et al., 1995;
acetyltransferase protein P/CAF (Yang et al., 1996). Re-Glass, 1994; Mangelsdorf and Evans, 1995). Structure
cently, it was found that CBP and p300 themselves have
intrinsic histone acetyltransferase (HAT) activity (Ban-
nister and Kouzarides, 1996; Ogryzko et al., 1996).#To whom correspondence should be addressed.
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Therefore, it appears that CBP/p300 and its associated
protein P/CAF play a pivotal role in the control of cell
growth and differentiation by integrating diverse signals
for gene expression and function through direct con-
tacting of the transcription machinery and/or targeted
modification of the chromatin structure.
Although initially isolated as a protein interacting with
progesterone receptor, SRC-1 was also found to be able
to interact with several members of the nuclear receptor
family in a hormone-dependent manner (Onate et al.,
1995; Hanstein et al., 1996; Kamei et al., 1996; Yao et
al., 1996). It was demonstrated to enhance the ligand-
dependent transactivation activity of PR, GR, ER, TR,
and RXR (Onate et al., 1995). Through interaction
screening, genes encoding proteins sharing sequence Figure 1. ACTR Stimulates RAR Function in Yeast
homology with SRC-1 were also cloned and designated Yeast strain RH4XRE constitutively expressing hRARb was trans-
formed by different clones of ACTR isolated from the cDNA libraryas either GRIP1 (Hong et al., 1996) or TIF2 (Voegel et
screening. Three individual transformants from each clone wereal., 1996). They were shown to associate with members
streaked on the selection medium (see Experimental Procedures)of the nuclear receptors family and augment the trans-
with or without 5 mM atRA. After incubation for 3 days at 308C, sizes
activation activity of steroid receptors such as GR and (mm) of individual colonies were scored as indicated. Individual
ER (Voegel et al., 1996). In any case, however, the mech- transformants from each clone gave the same results. Schematics
anism by which those cofactors function in mediating of various ACTR isolates fused to the Gal4 activation domain present
in pGAD10 vector (Clontech) are shown. Clone A77 is the full-lengthhormone signaling by receptors is still largely unknown.
clone of ACTR. Other clones are aligned relative to A77. Clone A59In addition, the functional domains of those cofactors
harbors a 65-amino-acid naturally occurring deletion (Figure 2B).have not been defined.
Targeted chromatin structure changehas been postu-
We constructed a yeast strain (RH4xRE) in which twolated to associate with the regulation of gene expression
chromosomally integrated reporter genes (HIS3 andby nuclear receptors (Zaret and Yamamoto, 1984; Truss
lacZ) are under the control of retinoic acid responseet al., 1995; Wong et al., 1995). Recent biochemical and
elements (RARE). The yeast strain constitutively ex-genetic studies support the notion that hyperacetylation
pressing full-length hRARb was then transformed withof core histones is a characteristic of gene activation,
a human GAL4 activation-domain fusion cDNA library.and, conversely, histone deacetylation is involved in
The transformants were plated on selection mediumtranscriptional repression (reviewed by Brownell and
containing 5 mM all-trans retinoic acid (atRA). AmongAllis, 1996; Wolffe and Pruss, 1996). One striking exam-
the positive colonies analyzed, we identified cDNAs en-ple is the demonstration made by us and others that
coding partial or full-length proteins for RXRa, RIP140,nuclear receptor corepressors SMRT and N-CoR form
and SRC-1. However, most other clones are repeatedcomplexes with Sin3 and histone deacetylase proteins,
isolates and share overlapping sequences (Figure 1).suggesting that chromatin remodeling by histone
One of them (clone A77) has a 6.7 kb cDNA insert thatdeacetylation is a possible mechanism for receptor-
encodes an ORF of 1412 amino acids with predictedmediated repression (Heinzel et al., 1997; Nagy et al., 1997;
MW 154 kDa. This cDNA clone contains an in-framereviewed by Pazin and Kadonaga, 1997; Wolffe, 1997).
stop codon upstream of its first methionine and down-In order to understand the processes of hormone-
stream of the 39 end of the coding sequences for GAL4dependent transactivation by nuclear receptors, we
activation domain in the vector and therefore is consid-have performed functional analysis of a novel coactiva-
ered to be a full-length clone. Interestingly, more thantor for nuclear hormone receptors, designated as ACTR.
half of the receptor-interacting clones analyzed lack anWe found that not only can ACTR function by recruiting
in-frame GAL4 activation domain (AD) (Figure 1), sug-HAT proteins CBP/p300 and P/CAF, but by itself it is a
gesting that they encode peptides that are able to inter-HAT. ACTR is able to acetylate both free histones and
act with receptors and stimulate transcription indepen-nucleosome histones with substrate preference on his-
dent of Gal4-AD in yeast. Reintroducing these clonestones H3 and H4. These results suggest that nuclear
into yeast strain RH4xRE harboring expression vectorsreceptors target at least three different and self-inter-
for hRARb confers strong hormone- (atRA-) dependentacting HAT activities (including ACTR or related pro-
growth. In contrast, yeast expressing only RAR or anyteins, CBP/p300, and P/CAF) to promoters, indicating
of the clones alone fail to grow on the selection platesa critical role for chromatin remodeling in hormonal sig-
(Figure 1 and data not shown). These results indicatenaling.
that the peptides encoded by these clones are able to
stimulate the transactivation activity of liganded recep-Results
tors in yeast.
The deduced amino acid sequence of the full-lengthIsolation of ACTR, a Novel Member of the Receptor
clone (ACTR) is shown in Figure 2A. It shows regionalCoactivator Family That Enhances the
sequence similarities to SRC-1 and TIF2/GRIP1 (FigureTransactivation Function of RAR in Yeast
2B). The most prominent region sharing high homologyThe yeast one-hybrid selection scheme was employed
to identify proteins that interact with nuclear receptors. (z80% similarity) among the three members is the
Nuclear Receptor Coactivator ACTR Is a HAT
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Figure 2. Sequence and Expression of ACTR
(A) Amino acid sequences of ACTR. Closed
triangle indicates the point from which an
N-terminal variant clone A94 (data not shown)
differs from ACTR (A77). Open triangles indi-
cate the endpoints of a fragment that is miss-
ing in clone A59. The initiation codon of clone
A38 is indicated by an arrow. The potential
receptor interaction motifs are underlined.
(B) Schematic alignment of ACTR, hSRC-1
(full-length), and hTIF2. Regions in TIF2 and
SRC-1 with significant homology are aligned
with ACTR, and percentages of amino acids
identical to ACTR are indicated. Functional
domains or regions identified in this study
and others are also indicated.
(C) Northern blot analysis of ACTR in different
human tissues (a) and cancer cell lines (b).
The human cell lines are as follows: HL60,
promyelocytic leukemia cell line; Hela, cervi-
cal carcinoma cell line (S3); K562, chronic my-
elogenus leukemia cell line; Molt4, lympho-
blastic leukemia cell line; Raji, Burkitt's
lymphomacell line;SW480, colorectal adeno-
carcinoma cell line; A549, lung carcinoma cell
line; G361, melanoma cell line. The relative
positions of RNA markers (kb) are at the left
side of each panel.
N-terminal 280 amino acid fragment (Figure 2B). Inter- Sequencing analysis of some of the clones isolated
revealed multiple potential alternative splicing variantsestingly, this region bears sequence homology with the
PAS and helix-loop-helix (HLH) domains that are con- of ACTR (Figure 2A), including a 65-amino-acid deletion
(clone A59, Figure 1), which is also observed in TIF2served among a family of nuclear proteins and believed
to be involved in DNA binding and heterodimerization (Voegel et al., 1996). Like mSRC-1 (Kamei et al., 1996),
ACTR was also found to have variants resulting fromamong the family members (for review, see Hankinson,
1995). The function of these domains in the receptor potential alternative splicing at its N terminus (Figure 2A
and data not shown). These similarities further establishcoactivator family is not yet clear at present. Other re-
gions that are relatively conserved encompass amino that ACTR, SRC-1, and TIF2/GRIP1 define a coactivator
gene family and raise the possibility that distinct rolesacid sequences rich in serine/threonine or glutamine
(Figure 2). However, only subfragments of these regions may be played by these splicing isoforms.
The mRNA level of ACTR varied highly among humanare mapped to distinct functional domains mediating
receptor interaction or transactivation, as described be- tissues examined by Northern analysis (Figure 2Ca). The
transcript with apparent length of z9.2 kb is abundantlow, indicating that the primary sequence features do
not correspond to specific functions of the protein. in heart, skeletal muscle, pancreas, and placenta and
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is relatively low in brain, very low in lung and liver, and
barely detectable in kidney. Shorter transcripts could
also be detected in different tissues with lower abun-
dance. Similar to the tissue expression profile, human
cancer cell lines examined also showed restricted ex-
pression of ACTR (Figure 2Cb).
ACTR Enhances the Transactivation Function
of Nuclear Receptors in Mammalian Cells
The ability of ACTR to stimulate receptor function in
yeast prompted us to test whether similar activities can
be detected in mammalian cells. Transient transfection
was initially performed in A549 human lung carcinoma
cell line in which low level of ACTR expression was
detected (Figure 2C). As shown in Figure 3A, cotransfec-
tion of these cellswith expression vectors for ACTR or an
N-terminal deletion variant (A38, Figure 2A) significantly
increased RAR-mediated induction of the bRARE-tk-luc
reporter gene activity (compare Figure 3A, lanes 3 and
4 to lane 2). Similar results were obtained in CV-1 cells
(data not shown). To determine whether ACTR stimu-
lates other nuclear hormone receptors, similar transfec-
tion experiments were carried out in CV-1 and HeLa
cells as shown in Figures 3B, 3C, and 3D. Introducing
only a hTRb expression plasmid into CV-1 cells led to
a modest increase in reporter DR4-tk-luc activity in the
presence of T3 (Figure 3B, lane 2). When ACTR and its
derivative A38 are cotransfected with TR, the reporter
activity is remarkably increased (Figure 3B, lanes 3 and
4). The strongest effects were seen with RXR on the
ApoAI RXRE tk-luc reporter (z4-fold) (Figure 3C, lanes
2 and 3). We have also performed the cotransfection
experiments with VDR, GR, and ER and observed similar
effects in each case (Figure 3D and data not shown).
These results indicate that ACTR is indeed a nuclear
receptor coactivator.
Figure 3. ACTR Stimulates the Transactivation by Nuclear Recep-
tors in Mammalian Cells
ACTR Interacts with Nuclear Hormone Receptors Luciferase reporter gene activities under the control of bRARE-tk
in an Agonist- and AF2/tc-Dependent Manner (A), DR4-tk (B), ApoA1-RXREx4-tk (C), and MMTV (D) promoters
were measured (see Experimental Procedures) from extracts ofTo test whether ACTR interacts with receptors directly,
A549 lung carcinoma cells (A), CV-1 cells (B and C) and HeLa cellswe first performed series of experiments using glutathi-
(D) after the cells were transiently transfected by the correspondingone-S-transferase (GST) pull-down assays (Figures 4A
reporter and expression plasmids. Relative luciferase activities in
and 4B). ACTR protein (aa 493 to C terminus) was ex- the presence (solid bars) or absence (hatched bars) are presented
pressed using baculovirus system and purified as GST in (A), (B), and (C) after being normalized by the internal control
fusion. As shown in Figure 4A, in the presence of their b-gal activities. The fold of hormone induction in (D) is derived from
the normalized luciferase activity in the presence of dexamethasonecognate ligands, a large portion (approximately 20% to
divided by the activity in the absence of hormone, which was essen-40% of the input) of 35S-labeled receptor proteins were
tially not affected by the introduction of ACTR or hSRC-1 expressionspecifically retained by the GST-ACTR fusion protein
plasmids. The ligands and their final concentrations used in the
immobilized on glutathione-agarose beads (lanes 4, 8, transfection are as follows: (A), atRA (100 nM); (B), T3 (100 nM); (C),
and 12), while no significant binding was observed either LG69 (100 nM); and (D), Dex (25 nM). ACTR-A38 is a shorter version
in the absence of ligands or by GST alone (lanes 2, 3, of full-length ACTR (see Figures 1 and 2 for comparison).
6, 7, 10, and 11). Thus, ACTR is able to interact with
several members of the receptor superfamily in a ligand-
dependent manner in vitro. We next tested if mutations fected cells. As shown in Figure 4C, lane 1, GAL4-DBD-
ACTR alone displays significant reporter activity due toin C-terminal activation domain (AF2/tc) affect ACTR
binding. As shown in Figure 4B, wild-type RXR interacts the presence of intrinsic activation functions (see be-
low). Nonetheless, cotransfection with VP16-receptorwith ACTR in the presence of its agonist LG69 (lane 4),
while point mutations at positions 450 (F450P) or 451 ligand-binding domains (LBDs) dramatically increased
the reporter gene activity in the presence of T3 (lane 2),(L451A) either abolished or severely diminished this as-
sociation (lanes 6 and 8). LG69 (lane 4) and 1,25-(OH)2-D3 (lane 6), although in the
cases of RAR and ER, the increase of reporter geneGAL4-DBD fusion of ACTR was used to demonstrate
in vivo interaction with receptors in transiently trans- activity is relatively low (lanes 3 and 5). Taken together,
Nuclear Receptor Coactivator ACTR Is a HAT
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ACTR Contains Multiple Receptor
Interaction Domains
To map the receptor-interaction domain (RID) in ACTR,
deletion constructs were generated and used in mam-
malian two-hybrid assay as described above. Results
shown in Figure 5A indicate that the central region (aa
596 to 833) of ACTR is able to associate with nuclear
hormone receptors. This is in agreement with the data
published for SRC-1 (Yao et al., 1996) and TIF2 (Voegel
et al., 1996) and with our results of library screening
where all the clones isolated share the central region
(Figure 1). To further map the RID, more deletions were
made within the central fragment (aa 596±833), and a
200-amino-acid fragment (aa 621±821) was found to
contain all the activity to interact with different receptors
tested (Figure 5Ba) and therefore named as ACTRRID.
Interestingly, when this 200-amino-acid fragment (aa
621±821) was subcloned as two smaller fragments (aa
621±728, N-RID and aa 729±821, C-RID), each retained
the ability to interact with RAR, RXR, and TR in hormone-
dependent fashion (Figures 5Bb and 5Bc). To confirm
the above transfection-based observations, individual
RID fragments were made as GST fusion proteins and
tested in the in vitro GST pull-down assay. As shown in
Figure 5C, in the presence of hormones, both N-RID and
C-RID are able to bind independently to the RAR. Similar
results were obtained for RXR and TR (data not shown).
We thus conclude that ACTR has at least two separable
RIDs located in its central region.
ACTR Associates with Receptors on Hormone
Response Elements
To characterize further interaction between ACTR and
receptor homo- and heterodimers, we have performed
gel mobility shift assays using purified proteins. Results
shown in Figure 5D indicate that, in the absence of
ligands, no significant association of ACTR is detected
with RXR/RAR and RXR/TR heterodimers or RXR homo-
dimers (lane 5 in Figure 5Da, lanes 3 and 7 in Figure 5Db,
and lane 6 in Figure 5Dc). In contrast, in the presenceFigure 4. ACTR Association with Nuclear Receptors Is Ligand and
of agonist, receptor±DNA±ACTR complexes are readilyAF2 Dependent
observed (lanes 6 and 7 of Figure 5Da with atRA and(A) In vitro translated and 35S-labeled full-length receptor (hRARa,
RAR synthetic agonist TTNPB; lanes 4 and 8 of FigurerTRa, and hVDR) products were incubated with GST or GST-ACTR
(493 to C terminus) immobilized on the glutathione beads in the 5Db with T3; lanes 7 and 8 with 9-cis RA and RXR
presence or absence of 1 mM of corresponding ligands (Am580, specific agonist LG69). Similar results were obtained by
lane 4; T3, lane 8; and 1,25-(OH)2-D3, lane 12). Labeled proteins using larger ACTR fragments (aa 493 to C terminus)
retained on the beads after extensive washing were analyzed by without the GST moiety (data not shown). Recently, a
SDS-PAGE and autoradiography, together with 20% of the trans-
novel RXR homodimer antagonist (LG100754) was foundlated products used in each incubation (INPUT).
to be able to activate specifically RAR/RXR heterodimer(B) In vitro translated full-length ACTR was incubated with GST or
(Lala et al., 1996). As predicted, LG100754 did not pro-GST fusions of wt or mutant hRXRa LBD.
(C) The interaction of ACTR (394 to C terminus) with receptor LBDs mote the association of ACTR with RXR homodimers
in vivowas measured as luciferase reporter activities in the presence (lane 9 of Figure 5Dc) but did induce ACTR binding to
(solid bars) or absence (hatched bars) of the corresponding hor- the heterodimer (lane 8 of Figure 5Da). It should be noted
mones (100 nM T3, lane 2; 100 nM Am580, lane 3; 100 nm LG69, that in the gel-shift assays, the recruitment of ACTR to
lane 4; 50 nM b-estradiol, lane 5; and 100 nM 1,25-(OH)2-D3, lane 6) receptor±DNA complex does not incur significantby the mammalian two-hybrid assay performed in CV-1 cells. The
change in the affinity of receptors to hormone responseMH100x4-tk-luc reporter used has four GAL4-binding sites. Note
elements (Figure 5D; compare the receptor±DNA com-that GAL4-DBD-ACTR fusion exhibits significant level of reporter
activity (lane 1) due to the transactivation function of ACTR as de- plex formation in the presence and absence of ACTR),
scribed in the text. suggesting that ACTR probably does not function
through stimulating receptor DNA binding.
CBP/p300 is an ACTR Cofactor
the results from both the in vitro and in vivo experiments To gain insight into its mechanism of activation, GAL4-
reveal ACTR directly binds nuclear receptor LBDs in an DBD fusions of ACTR fragments were used to map puta-
tive activation domains (Figure 6A). Truncation analysisagonist- and AF2/tc-dependent manner.
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Figure 5. ACTR Has Two Receptor-Interaction Domains and Associates with Receptors on DNA Elements
Mammalian two-hybrid assay was used (A) to assess the ability of ACTR derivatives to interact with TR in the presence (solid bars) and
absence (hatched bars) of 1 mM T3 and (B) to measure the interaction of the receptor-interaction domain (RID, [a]) and its subdomains (N-RID,
[b]; C-RID, [c]) of ACTR with different receptors in the presence (solid bars) or absence (hatched bars) of 1 mM ligands (T3 for TRb, Am580
for RARa, and LG69 for RXRa). Note that data from the same experiment is plotted at three different scales. (C) In vitro translated hRARa
was incubated with GST or GST-ACTR-RIDs immobilized on glutathione beads in the presence or absence of 1 mM of Am580. Retained
proteins were analyzed by SDS-PAGE and autoradiography, together with 20% of the translated products (INPUT).
(D) Gel mobility shift assays were performed with purified GST-ACTRRID (aa 621±821) and full-length nuclear receptors in the presence or
absence of 1 mM ligands as indicated. The positions of nuclear receptor±DNA complexes and ACTR±receptor±DNA complexes are indicated.
Free probes as indicated at the bottom of each panel are omitted.
reveals the region to be localized within the C-terminal 6B, lane 4, Figure 6D, lane 10, and data not shown).
Therefore, we have linked the ability of ACTR to activatehalf of ACTR (aa 827 to C terminus) (Figure 6A, lane 6).
Through further N- and C-terminal deletion analysis, two transcription to apparently recruiting the acetyltransfer-
ase CBP/p300. To assess the importance of the CBPseparable activation domains (AD-A and AD-B) were
identified. As shown in Figure 6B, additional deletions interaction, an appropriate deletion mutant (aa 1018±
1088) of ACTR was constructed. As shown in Figure 6E,localize AD-A to a fragment of 50 amino acids (aa 1039±
1088). The small size of this fragment suggests it may while transient cotransfection of CV-1 cells with wild-
type ACTR strongly augments GR induction of thefunction as an interaction domain to recruit another co-
activator. While AD-A fails to interact with TBP, TFIIB, MMTV reporter (compare lanes 2 and 3 with lane 1), the
CBP interaction domain (CID) deletion mutant shows noand the TAFIIs (data not shown), a strong interaction
with CBP was observed (Figure 6C, aa 1018±1290). This effect above background (lanes 4 and 5). This result
strongly supports the notion that CBP is an essentialinteraction is mediated by the glutamine-rich region of
CBP (aa 1891 to C terminus) (data not shown). Further component of the activation complex.
analysis indicates that the fragment of ACTR (aa 1018±
1088) that mediates the interaction with CBP is the same ACTR Recruits P/CAF
As CBP/p300 interact with both ACTR and P/CAF, weregion that harbors the strong autonomous transactiva-
tion function of ACTR (Figure 6B, lane 6, and Figure tested the potential interaction of ACTR with P/CAF.
Flag-tagged P/CAF was expressed and purified on6D, lanes 9, 11, and 12). In contrast, the less active
C-terminal fragment shows no significant interaction Flag-Ab agarose beads and used in the pull-down ex-
periment. Results shown in Figure 7A indicate that ACTRwith either CBP or TBP, the TAFIIs, and TFIIB (Figure
Nuclear Receptor Coactivator ACTR Is a HAT
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Figure 6. ACTR Transactivation Domain Interacts with CBP
(A and B) The indicated deletions of ACTR were made and fused to Gal4-DBD. These derivatives were then tested on a luciferase reporter
under the control of GAL4-binding sites.
(C and D) Interaction of ACTR derivatives with CBP were determined by GST pull-down assay similar to the ones described in Figures 5 and
7 with in vitro translated VP16-CBP (aa 1891 to C terminus) fusion (C) or GAL-ACTR derivatives (D) and GST-ACTR (C) or GST-CBP (D). Note
that 40% of the input translation product was loaded to the SDS-PAGE gel in (D).
(E) Transient transfections were performed essentially the same as in Figure 4. Five nanograms (lanes 2 and 4) or 15 ng (lanes 3 and 5) per
well of plasmid-encoding ACTR full length (lanes 2 and 3) or ACTR CID deletion (lanes 4 and 5) was used in transfection of 48-well plates of
CV-1 cells.
indeed is able to interact with P/CAF in vitro (lane 3). (Figure 8B). The data clearly show that the histone ace-
tylase activity cofractionates with ACTR and not with anySimilar results were obtained by yeast two-hybrid assay,
as shown in Figure 7B. Thus, ACTR independently inter- other proteins. Moreover, the histone acetylase activity
also cofractionated with ACTR on a Mono Q columnacts with both CBP/p300 and their associated factor
P/CAF, serving as a docking platform to bridge the HAT (data not shown). Since only one polypeptide, corre-
sponding to ACTR, chromatographs with histone ace-protein complex to DNA bound nuclear receptors.
tylase activity in two separation methods that rely on
totally different polypeptide characteristics, it seemsACTR Has Intrinsic HAT Activity
likely that the histone acetylase activity is intrinsic toGiven that intrinsic HAT activity has been found in vari-
ACTR itself and not due to the presence of an associatedous coactivators, including GCN5 (Kuo et al., 1996),
or contaminating histone acetylase activity.CBP/p300 (Ogryzko et al., 1996; Bannister and Kouza-
In order to determine which histones are acetylatedrides, 1996), P/CAF (Yang et al., 1996), and TAFII 250
by ACTR, we performed histone acetylase assays with(Mizzen et al., 1996), such activity might be a general
either free core histones or mononucleosomes and ana-feature of other coactivators. Based on this hypothesis,
lyzed the products of the reaction by SDS-PAGE fol-we tested Flag-tagged full-length ACTR protein ex-
lowed by autoradiography (Figure 8C). ACTR acetylatedpressed ina recombinant baculovirus system for histone
primarily histones H3 and H4 on both free histone andacetylase activity. Our initial data demonstrated the
mononucleosomes from HeLa cells, while a low level ofpresence of histone acetylase activity in this preparation
acetylation of H2b can be detected when free histonesof ACTR. In order to determine whether the histone ace-
are used as substrate (lanes 2 and 4). Control samplestylase activity is intrinsic to ACTR, the affinity-purified
where ACTR was replaced with bovine serum albuminACTR was resolved on a 10%±30% glycerol gradient.
demonstrated barely detectable background acetyla-The gradient fractions were analyzed by SDS-PAGE
(Figure 8A) and assayed for histone acetylase activity tion of histones (lanes 1 and 3). When histones were
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replaced in the reaction by bovine serum albumin or
lysozyme, no acetylation of these lysine-rich nonhistone
proteins was detected (data not shown). Thus, ACTR
appears to define a novel class of histone acetylase with
clear activity on both free core histones and nucleo-
somes.
We have localized the enzymatic activity in ACTR by
generating a variety of truncated ACTR constructs that
were then expressed and purified from either insect cells
or Escherichia coli. Constructs 1 to 3 (Figure 8D) show
that either Flag- or GST-tagged ACTR variants from
baculovirus vectors localize HAT activity to the C termi-
nus of z400 amino acids. Construct 5 shows the small-
est region (aa 1092±1292) retaining HAT activity that
deletes both the CID and the extreme C terminus. To rule
out the possibilty that endogenous insect cell proteins
might contribute to the HAT activity, we expressed in
E. coli a C-terminal segment of ACTR (aa 1018 to C
terminus, construct 4) and found that the GST fusion is
a potent HAT. In contrast, purified N-terminal or other
GST fusions (constructs 6, 7, and 8) are completely inac-
tive. Together, this work establishes that histone ace-
tylase activity is an intrinsic ACTR function.
Discussion
This work describes the isolation and functional analysis
of a novel nuclear receptor coactivator (ACTR) and de-
fines a plausible biochemical pathway for its action.
ACTR appears to exert its regulatory effects in two dis-
tinct biochemical steps. First, ACTR associates with
both CBP/p300 and P/CAF and thus functions to recruit
two transcriptional cofactors to the nuclear receptor±
DNA complex. The ability of ACTR to recruit these cofac-
tors appears to be essential for its positive function and
is consistent with previous studies demonstrating the
essentiality of CBP in receptor function and the essen-
tiality of P/CAF in CBP function. Secondly, we demon-
strate that ACTR possesses intrinsic HAT activity. This
Figure 8. ACTR Is a HAT
(A) SDS-PAGE analysis of glycerol gradient fractions of recombinant
ACTR. A 7.5 ml aliquot of the indicated fractions was separated on
a 4%±20% SDS-PAGE gel and stained with Coomassie blue. Two
microliters of input (IP) was also analyzed. The protein correspond-
ing to full-length ACTR is indicated by an arrow.
(B) Histone acetylase activity of glycerol gradient fractions of ACTR.
A 5 ml aliquot of the indicated fractions was assayed for histone
acetylase activity in a histone filter-binding assay. The levels of
enzyme activity are represented as cpm of radioactive [3H]acetate
transferred from acetyl-CoA to histone.
(C) Acetylation profiles of the substrate specificity of ACTR. Core
Figure 7. ACTR Interacts with P/CAF histones (lanes 1 and 2) or mononucleosomes (lanes 3 and 4) were
incubated with BSA (lanes 1 and 3) or recombinant ACTR (lanes 2(A) In vitro translated and 35S-labeled ACTR was incubated with M2
and 4). [14C]-acetylated histones were detected by autoradiographyAb agarose beads (lane 2) or Flag-P/CAF immobilized on the beads
after separation by SDS-PAGE.(lane 3). Labeled peptides retained on the beads after extensive
(D) HAT activity in ACTR is localized in the C-terminal region. Full-washing were analyzed by SDS-PAGE and autoradiography, to-
length or truncated derivatives of ACTR were expressed as eithergether with 10% of the translated products used in the incubation
GST (constructs 2, 4, 6, 7, and 8) or Flag (constructs 1, 3, and 5)(INPUT).
fusions and purified from either E. coli (constructs 4, 6, 7, and 8) or(B) The interaction of ACTR with P/CAF in yeast was measured as
Sf9 cells (constructs 1, 2, 3, and 5). Liquid HAT assays were per-b-galactosidase activity in yeast strain Y190 that was transformed
formed using 1 mg/ml of calf thymus histones and z1 mg purifiedwith GAL4 activation domain fused to full-length ACTR and Gal4-
ACTR proteins.DBD (lane 1) or Gal4-DBD fused to full-length P/CAF (lane 2).
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is unexpected, since ACTR does not possess homology (NR-box) in TIF1 b proteins (Le Douarin et al., 1996).
In addition, the well-conserved C-terminal region (CID)to other known HATs and thus apparently defines a
interacts strongly with CBP and corresponds to a potentnovel class of these regulatory enzymes. Thus, ACTR
transactivation domain.is both a HAT and by virtue of its ability to bind both CBP
A second feature of this gene family is their alternativeand P/CAF promotes the formation of a multisubunit
splicing products detected by cDNA library screeningactivation complex. Interestingly, while all currently
in this study (Figure 2) and others (Kamei et al., 1996,identified HATs (including ACTR) are capable of ace-
Voegel et al., 1996), which presumably results in thetylating core histones H3 and H4, ACTR displays an
expression of variant coactivator proteins. While SRC-unusual additional activity as an effective acetylator of
1a was found to have another RID at its C-terminal endmononucleosomes, similar only to that observed in
(Figure 2B) (Onate et al., 1995, Kamei et al., 1996), inCBP/p300. In contrast, neither GCN5 (Kuo et al., 1996),
general, the functional differences of these variants areP/CAF (Yang et al., 1996), nor TAFII 250 (Mizzen et al.,
not understood. Nevertheless, the conservation of these1996) are capable of acting on H3 and H4 in mono-
splicing events suggests that distinct roles may benucleosomes. These results suggest a potential cooper-
played by these isoforms. In light of the recent observa-ative activity in which distinct histone acetylases with
tion that CBP/p300 is involved in multiple transactivator-different regulatory capacities mutually recruit each
mediated signaling pathways, it seems reasonable toother to provide a concerted regulatory effect. While the
speculate that ACTR and its family members, includingindividual roles of each HAT is not yet clear, it seems
their splicing variants, are likely to constitute a widelyunlikely that they subserve completely redundant func-
used coactivation complex.tions. Rather, it is possible that they will either modify
A third common characteristic of the coactivator fam-selective sites on the histone tails or act in an ordered
ily is the ability to interact with multiple members of thefashion to control different aspects of transcriptional
receptor superfamily with apparently different interac-activation.
tion strengths (this study and references in Introduction).Previous studies have suggested that liganded nu-
In addition, their tissue expression patterns are distinct,clear receptors may alter nucleosome structure and that
with ACTR being the most restricted (Figure 2C). Thus,histone acetylation may be sufficient to activate a hor-
it is conceivable that each member of this family couldmone-responsive promoter (Zaretand Yamamoto, 1984;
serve as a primary coactivator for a subset of receptors.
Fragoso et al., 1995; Wong et al., 1995; Bartsch et al.,
In a given cell type, however, which coactivator(s) is
1996). The relevance of this pathway is further substanti-
involved in a particular hormonal signaling pathway
ated by the observation that the recently characterized
would be determined by the expression level of both
transcriptional corepressor complex possesses histone
receptors and coactivators and possibly the interaction
deacetylase activity (Nagy et al., 1997). This argument
of receptors with other proteins such as promoter-spe-
is relevant since both the coactivators (such as CBP, cific transcription factors. Therefore, the seemingly re-
ACTR, and SRC-1) and the corepressors (such as SMRT dundant functions played by the different coactivators
and N-CoR) were isolated largelybased on their ability to may, in fact, add another level of complexity for cells
interact with nuclear receptors (Chen and Evans, 1995; to control precisely the level of gene expression in re-
Horlein et al., 1995). Thus, the demonstration of oppos- sponse to hormones.
ing enzymatic activities of these complexes suggests The results of this study suggest that nuclear recep-
that control of histone acetylation is indeed a critical tors recruit an enzymatic complex that includes at least
feature of hormone signaling. three distinct classes of mutually interacting HATs. In
The sequence homology between ACTR and two re- addition, multiple additional proteins may be present
lated cofactors, SRC-1 and GRIP/TIF2, defines a cofac- in the final complex (Fondell et al., 1996). Receptors
tor gene family and suggests that these other proteins apparently directly interact with at least CBP and ACTR
are likely to function as novelhistone acetylases. Indeed, to nucleate this complex and thus target it to the DNA
as anticipated, we have also demonstrated that SRC-1 template. This association is mediated by the LBD and is
exhibits HAT activity (data not shown). Several common hormone and AF2 dependent. Intrinsic to this activation
features are obviousamong this nuclear receptor coacti- process is the reversal of receptor-mediated transcrip-
vator family. First, they share a number of functional tional repression. In the repressive state, the receptors
domains (Figure 2B). One of the highly conserved re- associate with silencing proteins such as SMRT and
gions (more than 60% identity within z280 amino acids) N-CoR. Recent studies demonstrate that SMRT and
is located at the N-termini of all three members of this N-CoR associate with the corepressor mSin3A and the
family. Although this region does not appear to be re- histone deacetylase (HDAC-1) to form a transcriptional
quired for ACTR and SRC-1 to enhance receptor-medi- repressor complex (Nagy et al., 1997; Heinzel et al.,
ated transactivation (Figure 4) (Onate et al., 1995), it may 1997). This repressor complex is dissociated from the
still contribute to aspects of ACTR function. In contrast, receptor following addition of hormone. The resulting
the central conserved region of z200 amino acids com- allosteric changes then attract the ACTR±CBP±P/CAF
prises the RIDs and is essential for function. Although activation complex, which is composed of at least three
no apparent homology can be found among regions distinct HATs. In this model, we suggest that hormone
associated with receptor-interaction activity, computer signaling may function at least in part by controlling the
analysis indicates they all contain an amphipathic balance of competing enzymatic activities at a target
a-helical structure with conserved sequences LXXLL promoter. In this view, hormonal control of targeted
(Figure 2A). Interestingly, sequences resembling LXXLL chromatin remodeling may be a critical feature of physio-
logic homeostasis.were recently identified as the receptor-interaction box
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Experimental Procedures Glycerol Gradient Fractionation of Flag-Affinity
Purified ACTR
Full-length ACTR was cloned to pAcSG2 (Pharmingen) via PCR am-Yeast Strains and cDNA Library Screening
The yeast strain RH4XRE was derived from parental strain RH1533 plification with Flag sequence incorporated into the 59 primer. Sf9
cells infected with the recombinant Flag-ACTR baculovirus wereby integrating into its chromosome two reporter genes, HIS3 and
lacZ, following the procedure described previously (Gstaiger et al., harvested 48 hr postinfection and lysed in BCT 500 (20 mM Tris-
HCl [pH 8], 5 mM MgCl2, 500 mM KCl, 0.1% Tween-20, 1 mM PMSF,1995). The reporter genes were constructed by replacing the UAS
sequences in pLI4 and pBM1499 with 43 multimerized bRARE se- and 10 mM b-mercaptoethanol) supplemented with 10% glycerol
and complete protease inhibitor cocktail (Boehringer Mannheim).quence. Full-length hRARb was constitutively expressed in strain
RH4XRE by transforming the yeast with pG1-RARb (Chen et al., Recombinant protein was purified on M2-agarose (Kodak-IBI) and
eluted with Flag peptide according to the manufacturer's protocol.1993). For library screening, strain RH4XRE carrying pG1-RARb was
transformed with human leukemia GAL4 AD fusion cDNA library Approximately 5 mg of recombinant ACTR was applied onto a 4 ml
10%±30% glycerol gradient prepared in BCT 500 and centrifuged(CLONTECH). Approximately 2 3 107 transformants were selected
on plates with synthetic medium lacking histidine and leucine and in a Beckman SW-60 rotor for 15 hr at 485,000 3 g. The gradient
was fractionated into 200 ml aliquots. Each fraction was analyzedcontaining 5 mM atRA and 40 mM 3AT in order to suppress the
low level expression of HIS3 due to the transactivation activity of on a 4%±20% SDS-PAGE gel and assayed for histone acetylase
activity.liganded receptor. About 250 colonies that are 3AT resistant and
strongly blue were isolated for subsequent analysis. Among the
colonies analyzed, essentially all of them carried plasmids rendering Histone Acetylase Activity Assays
Histone acetylase assays were performed as previously describedthe yeast strain receptor and/or hormone-dependent growth on the
selection medium. Yeast liquid b-galactosidase assay was carried (Ogryzko et al., 1996) with the following modifications. Filter-binding
assays shown in Figure 8B were performed using 66 mg/ml of HeLaout in strain Y190 according to the manufacturer's protocol
(Clontech). core histones and 12 pmol of [3H]acetyl CoA (4.3 mCi/mmol, Amers-
ham Life Science Inc.). Assays in Figure 8D were performed with a
modification that calf thymus histones (Sigma Chemicals) were usedPlasmids and Transfection
as substrates and that GST or Flag-ACTR fusion proteins were usedExpression plasmid for full-length ACTR was constructed by intro-
as they were still associated with the agarose beads. The GST-ducing Kozak sequence and an Asp-718 site at the 59 end of clone
fusion proteins were expressed in and purified from E. coli strainA77 via PCR and then cloned into pCMX-PL2 vector as Asp-718
BL21(DE3)pLysS. For SDS-PAGE analysis of acetylated histones,and XhoI fragment. ACTR-A38 clone was introduced to pCMX-PL2
180 pmol of [14C]acetyl CoA (55 mCi/mmol, Amersham Life Sciencevia SalI site. Deletions of ACTR were made via PCR amplification
Inc.) and either 66 mg/ml of HeLa core histones or mononucleosome(Pfu DNA polymerase, Stratagene) of fragments of clone A77 se-
core particles were used. HeLa core histones and mononucleosomequences and subcloning them into pCMX-PL2. Constructs as GAL4-
core particles were prepared as described (Hayes et al., 1994).DBD fusion used in mammalian two-hybrid assays were made by
cloning PCR-amplified fragments of ACTR either into pM vector
Acknowledgments(Clontech) via BamHI site or into pCMX-Gal-N via Asp-718 and
BamHI. Transient transfection was performed on cells plated in 48-
We acknowledge Dr. David No for Northern analysis and Henrywell plates by lipofection. CMX-b-gal plasmid was used as an inter-
Juguilon and Sheryl Moles for technical assistance. We are gratefulnal control to normalize the luciferase activity. Each transfection
to Dr. John Schwabe for critical reading of the manuscript. We thankwas carried out in either duplicate or triplicate and repeated at least
Drs. M. Gstaiger and W. Schaffner for the gift of plasmids and yeasttwice.
strain RH1533. R. J. L. is a predoctoral fellow of the Lucille P. Markey
Charitable Trust. D. C. is a fellow of the Jane Coffin Childs Memorial
Pull-Down Assays and Gel Shift Assay Fund. R. M. E. is an Investigator of the Howard Hughes Medical
Usually, 50 ml of 40% GST-protein beads slurry, which contains Institute at the Salk Institute for Biological Studies. This work was
z0.5 mg of proteins and was resuspended in the binding buffer (20 supported by the Howard Hughes Medical Institute and National
mM HEPES [pH 7.9]; 100 or 150 mM NaCl; 1 mM EDTA; 4 mM MgCl2; Institutes of Health grants GM26444 and HD27183.
1 mM DTT; 0.02% NP-40; 10% glycerol supplemented before use
with 1 mg/ml BSA, 0.5 mM PMSF, and a protease inhibitors cocktail), Received June 9, 1997; revised July 3, 1997.
was mixedwith 10 ml of in vitro translation reactions with [35S]methio-
nine (Promega TNT kit) for 30 min at 48C. The beads were then References
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